| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.098 | 0.09 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |